We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-13.66%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.4B
AUM Growth
-$6.59B
(-16%)
Cap. Flow
+$586M
Cap. Flow
% of AUM
1.7%
Top 10 Holdings %
Top 10 Hldgs %
23.16%
Holding
1,447
New
124
Increased
589
Reduced
408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$95.6M |
| 2 |
Marvell Technology
MRVL
|
+$87.7M |
| 3 |
Adobe
ADBE
|
+$72.3M |
| 4 |
Sherwin-Williams
SHW
|
+$64.7M |
| 5 |
Tesla
TSLA
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$153M |
| 2 |
Deutsche Bank
DB
|
+$102M |
| 3 |
Procter & Gamble
PG
|
+$77.8M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$77.7M |
| 5 |
CERN
Cerner Corp
CERN
|
+$61.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.3% |
| 2 | Healthcare | 19.53% |
| 3 | Financials | 10.69% |
| 4 | Consumer Discretionary | 8.7% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
676
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.52M | 0.01% |
20,150
+10,500
| +109% | +$1.21M |
|
677
AGNC Investment
AGNC
$12.8B
| $2.51M | 0.01% |
227,034
-29,931
| -12% | -$355K |
|
678
Independence Realty Trust
IRT
$3.94B
| $2.51M | 0.01% |
122,987
-4,911
| -4% | -$118K |
|
|
ITCI
679
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.48M | 0.01% |
43,583
-917
| -2% | -$52K |
|
|
MRTX
680
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.46M | 0.01% |
37,140
-1,750
| -4% | -$111K |
|
681
Telkom Indonesia
TLK
$14.7B
| $2.46M | 0.01% |
92,500
| – | – |
|
|
FYBR
682
DELISTED
Frontier Communications
FYBR
| $2.46M | 0.01% |
+104,966
| New | +$2.68M |
|
683
GoDaddy
GDDY
$11.6B
| $2.45M | 0.01% |
35,286
-207
| -0.6% | -$15.7K |
|
|
GTM
684
ZoomInfo Technologies
GTM
$1.23B
| $2.43M | 0.01% |
71,302
-35,911
| -33% | -$1.58M |
|
685
Ultragenyx Pharmaceutical
RARE
$2.64B
| $2.4M | 0.01% |
40,360
-1,000
| -2% | -$61.5K |
|
686
Cytokinetics
CYTK
$10.8B
| $2.35M | 0.01% |
56,100
| – | – |
|
687
Molson Coors Class B
TAP
$7.93B
| $2.33M | 0.01% |
41,819
+6,046
| +17% | +$325K |
|
688
Corpay
CPAY
$26.3B
| $2.33M | 0.01% |
11,218
+1,615
| +17% | +$385K |
|
689
Medpace
MEDP
$16.8B
| $2.33M | 0.01% |
15,700
| – | – |
|
|
FOLD
690
DELISTED
Amicus Therapeutics
FOLD
| $2.3M | 0.01% |
217,700
+120,000
| +123% | +$988K |
|
691
Toll Brothers
TOL
$14B
| $2.3M | 0.01% |
52,800
+25,300
| +92% | +$1.18M |
|
692
Builders FirstSource
BLDR
$7.74B
| $2.29M | 0.01% |
43,915
+7,002
| +19% | +$429K |
|
693
XPO
XPO
$23.5B
| $2.28M | 0.01% |
+80,447
| New | +$2.56M |
|
694
Organon & Co
OGN
$3.58B
| $2.27M | 0.01% |
+66,888
| New | +$2.34M |
|
695
CubeSmart
CUBE
$9.23B
| $2.26M | 0.01% |
53,226
+3,378
| +7% | +$155K |
|
696
Paylocity
PCTY
$7.73B
| $2.25M | 0.01% |
12,800
+500
| +4% | +$91.1K |
|
697
Rexford Industrial Realty
REXR
$8.13B
| $2.25M | 0.01% |
39,047
+2,475
| +7% | +$170K |
|
698
Crown Holdings
CCK
$13.1B
| $2.23M | 0.01% |
24,165
+526
| +2% | +$56.2K |
|
699
Constellation Energy
CEG
$95.8B
| $2.23M | 0.01% |
+39,435
| New | +$2.37M |
|
700
UFP Industries
UFPI
$5.01B
| $2.21M | 0.01% |
33,630
+610
| +2% | +$46K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2022 Portfolio in Review
As of Q2 2022, DekaBank Deutsche Girozentrale held 1,447 positions worth $34.4B, down 16% from $41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale's Q2 2022 filing shows 124 new, 589 increased, 408 reduced and 84 closed positions. Its largest new stake was Marvell Technology: 1,546,996 shares worth $67.3M. The largest sale was Linde, an estimated $153M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q2 2022 buy was Marvell Technology: 1,546,996 shares worth $67.3M.
- DekaBank Deutsche Girozentrale added most to Meta Platforms (Facebook) in Q2 2022, an estimated $95.6M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2022 reduction was Linde, cutting an estimated $153M.
- DekaBank Deutsche Girozentrale fully exited Cerner Corp in Q2 2022, selling an estimated $61.9M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.4B portfolio in Q2 2022.
- DekaBank Deutsche Girozentrale opened 124 new positions and closed 84 in Q2 2022.
- DekaBank Deutsche Girozentrale's portfolio value fell 16% quarter-over-quarter to $34.4B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2022, filed 3 Aug 2022.